Our work identified three haematologic/immune system-specific expressed genes, GZMA, PRC1, and TTK, as potential biomarkers for the early diagnosis and treatment of RA and provided insight into the mechanisms of disease development in RA at the transcriptome level. Here, GZMA is linked to rheumatoid arthritis.